ART BioScience

Genetic Therapies for Duchenne Muscular Dystrophy

Health Tech & Life Sciences
Active
Pre-Funding Rehovot, Israel Founded 2015
Website ↗
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2015
Headcount
7
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

ART BioScience specializes in the use of novel messenger RNA technologies for the development of therapeutics that may potentially change the course of Duchenne Muscular Dystrophy.

The company’s initial work began with lipids licensed from the laboratory of Professor Dan Peer. ART BioScience has optimized these lipids for effective muscle delivery based on a proprietary LNP-based formulation. The delivery system enables the efficient transfer of mRNA to the muscles via systemic administration. The technology reflects years of work scanning numerous lipids and optimizing the formulations for delivery.

ART BioScience was founded by Mr. Oren Ozeri and Mr. Alon Hazan, fathers of two children diagnosed with Duchenne Muscular Dystrophy.

Q&A

What is ART BioScience's primary focus?
ART BioScience specializes in developing genetic therapies for Duchenne Muscular Dystrophy using novel messenger RNA technologies.
When was ART BioScience founded?
ART BioScience was founded in July 2015.
Who are the founders of ART BioScience?
ART BioScience was founded by Mr. Oren Ozeri and Mr. Alon Hazan, both fathers of children diagnosed with Duchenne Muscular Dystrophy.
What is the current employee count at ART BioScience?
ART BioScience has 1-10 employees.
What is ART BioScience's current funding stage?
ART BioScience is currently in the Pre-Funding stage.
What technology does ART BioScience utilize for its therapies?
ART BioScience uses a proprietary LNP-based formulation for effective muscle delivery of mRNA via systemic administration, based on lipids licensed from Professor Dan Peer's laboratory.
Where is ART BioScience headquartered?
ART BioScience is headquartered in Rehovot, Center District, Israel.
Who is the CEO and CTO of ART BioScience?
Oren Ozeri is the Co-founder, CEO & CTO of ART BioScience.

Team · 2

Founder · Co-founder, CEO & CTO
LinkedIn ↗
Alon Hazan
Founder · Co-founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenesMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Tags

bioconvergencechronic-patientsneurologygeneticsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteartbioscience.com

Identifiers & details

Founded2015-7
Employees (exact)7

Radar intelligence

Web history (Wayback)

Domainartbioscience.com

Certificate / subdomain footprint

Subdomains2